[Transplantation of mesenchymal stem cells transfected with hepatocyte growth factor gene improves heart function in rats with heart failure]
- PMID: 21158048
[Transplantation of mesenchymal stem cells transfected with hepatocyte growth factor gene improves heart function in rats with heart failure]
Abstract
Aim: To investigate the effects of hepatocyte growth factor gene transfected MSCs transplantation on cardiac function and fibrosis in rats heart failure model induced by adriamycin.
Methods: MSCs were isolated from SD rats by density gradient centrifugation, purified, and transfected with Ad-hHGF. ELISA were used to detect the protein expression of hHGF in these MSCs. Forty SD rats underwent intraperitoneal injection with adriamycin to induce heart failure model. 8 healthy rats served as control, 24 survival rats were randomly divided into 3 groups (n = 8): Rats in Ad-hHGF transfected MSCs group were injected with Ad-hHGF transfected MSCs 2 weeks after the establishment of the model, rats in MSC group injected with suspension of MSCs only, and model group was injected with cold culture fluid. Heart function was evaluated by a physiological recorder 4 weeks after cell transplantation. Myocardial cell morphology and interstitial collagen were studied by electron microscope and were stained by Sirus red. TGF-beta1 was detected by immunohistochemical method.
Results: (1) MSCs could be transfected efficiently by Ad-hHGF, manifested by a higher level of expression in vitro, persisting 14 days at least. (2) Four weeks after the cells transplantion, cardiac necrosis in MSC-hHGF rats was improved when compared with those in the MSCs (P < 0.05) and Model group (P < 0.01). The heart function of the MSC-hHGF rats was greatly improved with an significant increase in LVSP and + dp/dt(max), although LVEDP still highter than that of normal rats. (3) MSC-Ad-hHGF decreased Myocardial collagen content and the level of TGFbeta1 compaired with MSCs transplanted rats (P < 0.01).
Conclusion: Transplantation of HGF gene transfected MSCs improved heart function, decreased myocardial collagen and the level of TGFbeta1.
Similar articles
-
[Effects of myocardial transplantation of mesenchymal stem cells transfected with vascular endothelial factor gene on improvement of heart function and angiogenesis after myocardial infarction: experiment with rats].Zhonghua Yi Xue Za Zhi. 2006 Apr 18;86(15):1027-34. Zhonghua Yi Xue Za Zhi. 2006. PMID: 16784704 Chinese.
-
[Effect of combined therapy of granulocyte colony stimulating factor and bone marrow mesenchymal stem cells carrying hepatocyte growth factor gene on angiogenesis of myocardial infarction in rats].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2011 Jun;25(6):736-40. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2011. PMID: 21735790 Chinese.
-
MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis.Int J Cardiol. 2013 Sep 10;167(6):2524-32. doi: 10.1016/j.ijcard.2012.06.052. Epub 2012 Sep 13. Int J Cardiol. 2013. PMID: 22981278
-
Recent advances in the therapeutic efficacy of hepatocyte growth factor gene-modified mesenchymal stem cells in multiple disease settings.J Cell Mol Med. 2022 Sep;26(18):4745-4755. doi: 10.1111/jcmm.17497. Epub 2022 Aug 3. J Cell Mol Med. 2022. PMID: 35922965 Free PMC article. Review.
-
Can we remove scar and fibrosis from adult human myocardium?Eur Heart J. 2019 Mar 21;40(12):960-966. doi: 10.1093/eurheartj/ehy503. Eur Heart J. 2019. PMID: 30203057 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical